[Ampio Pharmaceuticals] grosses $16.9mm via follow-on
20:00 EDT 30 Jun 2012 | Elsevier Business Intelligence
[Ampio Pharmaceuticals Inc.] (working on therapies in the areas of male sexual dysfunction and inflammatory, eye, kidney, CNS, and metabolic diseases) has grossed $16.9mm through the follow-on public offering of 5.2mm common shares (including the ove..
Original Article: [Ampio Pharmaceuticals] grosses $16.9mm via follow-on
More From BioPortfolio on "[Ampio Pharmaceuticals] grosses $16.9mm via follow-on"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
